Kardigan
  • About Us
    • Purpose
    • Leadership
    • Partnering
    • Contact Us
  • Our Focus
    • Cardiac Intelligence
    • Development Pipeline
    • Genetic Dilated Cardiomyopathy
    • Moderate Calcific Aortic Valve Stenosis
    • Acute Severe Hypertension
    • Scientific Publications
    • Clinical Trials
  • Working Here
    • Kardigan Culture
    • Job Openings
  • Newsroom
    • Press Releases
  • Patients & Families
    • Patient Advocacy
Select Page

Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label Trial

by [email protected] | Feb 11, 2026 | Genetic Dilated Cardiomyopathy

  • About Us
  • Our Focus
  • Working Here
  • Newsroom
  • Patients & Families
  • Linked In
  • Privacy Policy
  • Terms of Use
  • Website by 22 Fillmore
© 2026 Kardigan. All rights reserved. KARDIGAN and the stylized K are trademarks of Kardigan, Inc.